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Abstract
Background: Organophosphates are the most frequently and largely applied insecticide in the world due to their
biodegradable nature. Gut microbes were shown to degrade organophosphates and cause intestinal dysfunction.
The diabetogenic nature of organophosphates was recently reported but the underlying molecular mechanism is
unclear. We aimed to understand the role of gut microbiota in organophosphate-induced hyperglycemia and to
unravel the molecular mechanism behind this process.
Results: Here we demonstrate a high prevalence of diabetes among people directly exposed to organophosphates in
rural India (n = 3080). Correlation and linear regression analysis reveal a strong association between plasma
organophosphate residues and HbA1c but no association with acetylcholine esterase was noticed. Chronic treatment
of mice with organophosphate for 180 days confirms the induction of glucose intolerance with no significant change
in acetylcholine esterase. Further fecal transplantation and culture transplantation experiments confirm the
involvement of gut microbiota in organophosphate-induced glucose intolerance. Intestinal metatranscriptomic and
host metabolomic analyses reveal that gut microbial organophosphate degradation produces short chain fatty acids
like acetic acid, which induces gluconeogenesis and thereby accounts for glucose intolerance. Plasma
organophosphate residues are positively correlated with fecal esterase activity and acetate level of human diabetes.
Conclusion: Collectively, our results implicate gluconeogenesis as the key mechanism behind organophosphate-
induced hyperglycemia, mediated by the organophosphate-degrading potential of gut microbiota. This study reveals
the gut microbiome-mediated diabetogenic nature of organophosphates and hence that the usage of these
insecticides should be reconsidered.
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Background
Organophosphates (OPs) are esters, amides, or thiol de-
rivatives of phosphoric acid synthesized first in the early
19th century. The history of the development of OPs is
amalgamated with wars [1]. They are used as pesticides
in agricultural fields, as chemical weapons in war fields,
as plasticizers, oil additives, and lubricants in industries.
Due to the advent of “Silent Spring” [2] and other envir-
onmental movements, organochlorine pesticides like
DDT were banned and that place was strongly grasped
by OPs in the 1970s [3]. Eventually, OP has become a
largely used insecticide in the world, accounting for
more than 40% of the pesticide market. Often less than
0.1% of pesticides sprayed are estimated to reach the tar-
get organism [4], while the remainder is deposited on
plant surfaces or tissues, soil, water, and air and ultim-
ately reaches off-target organisms including humans.
The existence of OP residues in different media includ-
ing air, soil, water bodies, vegetables, blood, urine, and
tissues of humans and other animals were detected
worldwide [5, 6].
In 1962, Carson designated OPs as one of the most
poisonous chemicals of the world [2]. OPs inhibit acetyl-
choline esterase (AChE) [7], which in turn induces
synapses of nervous and muscular systems leading to
agitation, hypersalivation, convulsion, respiratory failure,
and eventually death of insects and mammals. However,
various animal [8–10] and human studies [11–14] have
uncovered the association between OP exposure and
diabetic prevalence. OP-metabolizing microbes have
been identified in soil and other environments [15] and
intestinal bacteria were proven to degrade OP [16]. Ex-
posure to chronic OPs induces gut microbial dysbiosis
[17] and intestinal dysfunctions [18]. Trillions of mi-
crobes constituting the gut microbiota represent a vast
and rare repository of diet [19, 20] and xenobiotics me-
tabolizing machinery [21, 22]. Alterations in ecology and
physiology of gut microbiota affects the host metabolism
and thereby determines the transition between health
and disease [23] including diabetes [24, 25]. For instance,
gut microbiota was proven to mediate the glucose in-
tolerance induced by non-caloric artificial sweeteners
[26]. Thus, the present study is designed to explore the
effect of chronic OP exposure on glucose homeostasis
and to identify the role of gut microbiota in OP-induced
hyperglycemia.
Results
Plasma OP residues associated with human diabetes
Based on the survey executed among the pesticide users
including pesticide applicators, farmers, and pesticide
sellers in the villages of Vadapalanji Panchayat
(Additional file 1: Figure S1), we found OP constitutes
nearly 50% of insecticide usage (Additional file 1: Figure
S2A, Additional file 2: Table S1). Among the OPs,
monocrotophos (MCP), chlorpyrifos (CHL), malathion
(MAL), and methyl parathion (MPAR) are frequently
and extensively used (Additional file 2: Table S1). We
executed another survey among the people (n = 3080) in
the same villages. Age, sex, self-reported diabetic status,
familial diabetic, and OP exposure history were collected
from this rural population (Additional file 2: Table S2).
Our survey indicates the high prevalence of diabetics
(18.3%) among the people directly exposed to OP insec-
ticides while it was threefold lesser (6.2%) among the in-
directly exposed group (Fig. 1a, Additional file 1: Figure
S1B; adjusted odds ratio (OR), 1.4; 95% confidence inter-
val (CI), –0.74 to 2.47; Additional file 2: Table S3). To
study the influence of genetic factors, we analyzed the
familial diabetic history and found half of the diabetics
in both groups had no familial diabetic history
(Additional file 1: Figure S1C).
To validate the OP exposure and self-reported diabetic
status, blood samples were collected from a random
subpopulation (n = 802) that included non-diabetic (n =
554) and diabetic (n = 228) individuals. Details of age,
sex, height, weight, pesticide exposure history, diabetic
history, smoking, alcohol and tobacco usage, medica-
tions, and other disorders were collected using a stand-
ard questionnaire (Additional files 2: Table S4 and
Additional file 3). The diabetic status was validated by
HbA1c analysis and people with HbA1c ≥ 6.5 were con-
sidered as diabetic. Ninety percent of the self-reported
diabetic status coincided with HbA1c level (Additional
file 2: Table S4), the rest of them were under
hypoglycemic medications and hence considered as dia-
betic. In addition, 19% of the self-reported non-diabetic
participants in an earlier study were newly diagnosed as
diabetic in HbA1c analysis that indicates the higher bur-
den of diabetes in this rural community. To further val-
idate the OP exposure, we studied plasma AChE, which
is the target of OPs. Though 14.7% of the population
had AChE above reference limits, they were distributed
in both direct exposure and indirect exposure groups
(6:4 ratio) with no significant association (Rank sum P <
0.09, Fig. 1b). Similarly, no significant association was
observed in plasma AChE between diabetic and non-dia-
betic individuals (Rank sum P < 0.40, Additional file 1: Fig-
ure S3A).
The OP residues in the blood plasma were studied by
GC/MS and m/z fragments specific to each OP are
monitored by a single ion mode (Additional file 1: Figure
S4). MCP, CHL, MAL, and MPAR residues were de-
tected in 87.3%, 73.2%, 70.9%, and 68.3% of the study
population, respectively. Nearly 70% of the samples with
OP residues below detectable limits falls under the indir-
ectly exposed category (Additional file 2: Table S4). No
significant correlation was found between the total OP
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residues and plasma AChE level (Pearson Correlation
co-efficient (PCC) = 0.04, P = 0.22) and BMI (PCC =
−0.06, P = 0.07) (Additional file 2: Table S5).
On the other hand, after adjustment for confounding
variables, significant positive correlation was observed
between plasma OP residues (except MAL) and HbA1c
(Fig. 1c–e, Additional file 1: Figure S3B). The correlation
was stronger in the case of the direct exposure group
(PCC = 0.29, P < 0.01 for MCP; PCC = 0.07, P < 0.05 for
CHL; PCC = −0.15, P = 0.08 for MAL; PCC = 0.3, P <
0.01 for MPAR) than the indirect exposure group (PCC
= 0.07, P < 0.05 for MCP; PCC = 0.04, P < 0.05 for CHL;
PCC = 0.0004, P = 0.06 for MAL; and PCC = 0.173, P =
0.07 for MPAR) (Fig. 1c–e). For every unit increase in
the level of plasma OP residues, a corresponding in-
crease in HbA1c value was found by linear regression
analysis. The regression co-efficients (β) for direct ex-
posure category were 3.8 × 10−3 (P < 0.01), 2.1 × 10−3 (P
< 0.05), 7.2 × 10−7 (P = 0.08), and 2.4 × 10−4 (P < 0.01) for
MCP, CHL, MAL, and MAPR, respectively. In the case
of the indirect exposure category, the β values were
1.5 × 10−4 (P < 0.05), 1.2 × 10−3 (P < 0.05), 7.2 × 10−7 (P =
0.06), and 8.7 × 10−5 (P = 0.07) for MCP, CHL, MAL, and
MAPR, respectively (Fig. 1c–e).
By logistic regression, the multivariable adjusted ORs
for diabetes associated with the highest quartile of each
Fig. 1 Blood plasma OP residues correlate with self-reported exposure and diabetic status. a Prevalence of diabetics among humans exposed to
OP (n =1686) and not directly exposed to OP (n = 1394). The percentage of diabetic prevalence and non-prevalence are mentioned in the bars.
b Plasma acetylcholine esterase (AChE) of people indirectly exposed (n = 303) and directly exposed (n = 499) to OP. Dotted lines represent the
reference values for males (green) and females (pink). Regression plot of plasma OP residues vs. blood HbA1c indirectly exposed (n = 303) and
directly exposed (n = 499) to (c) MCP, (d) CHL, (e) MAL, (f) MPAR. Horizontal lines represent mean; error bars represent s.e.m; *P < 0.05 Rank sum,
Mann–Whitney U Test (b). The hollow circle represents individual values and straight line represents the trend line. *P < 0.05; **P < 0.01. PCC Pear-
son correlation coefficient, β regression coefficient (c–f)
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OP compared with its lowest quartile were 1.70 (95% CI,
0.86–1.37) for MCP (Ptrend < 0.001), 1.82 (0.31–1.25) for
CHL (Ptrend < 0.05), 1.08 (0.54–2.16) for MAL (Ptrend =
0.654), and 2.67 (1.23–2.80) for MPAR (Ptrend < 0.05)
(Additional file 2: Table S6). People with OP residues in
the highest quartile were largely diabetic in the case of
all four OPs (Additional file 1: Figure S5, Additional file
2: Table S7). Similarly, more than 50% of people in the
highest quartile of OPs were from the directly exposed
group and OP residues below the detectable limit were
largely distributed among the group with no direct ex-
posure to OPs (Additional file 1: Figure S6, Additional
file 2: Table S7). Altogether, this study indicates a prob-
able association between OP accumulation and diabetic
prevalence with no change in AChE activity.
Chronic OP impairs glucose tolerance and induces
oxidative stress
Since the human studies indicate the association be-
tween plasma OP residues and diabetes prevalence, we
examined whether chronic exposure to OP is a risk fac-
tor for hyperglycemia by studying a preclinical model of
OP exposure in BALB/c mice. MCP is identified as the
most frequently used insecticide in our survey
(Additional file 2: Table S1) and as our previous study
indicates that this OP induces hyperglycemia [10], we
employed MCP as the prototypical OP. Mice were ad-
ministered MCP orally at 10× theoretical maximum
daily intake (TMDI) dose (28 μg/kg body weight/day)
directly in drinking water (Additional file 1: Figure S7A).
TMDI for MCP (0.17 mg/day) [6] was calculated as per
WHO recommendations (1997) based on the maximum
residue limits (MRL) available for selected grains and
vegetables. Since, the level of residues in water, air, and
other eatables are not considered for TMDI calculation,
we provided 10X TMDI dose. The animals were pro-
vided pure water or MCP mixed water continuously
for 180 days, which is equivalent to 12–15 years of
human life.
No significant variation in body weight (P < 0.9999;
Additional file 1: Figure S7B), food, and water intake
(data not shown) were noticed between the control and
MCP-fed animals. MCP-fed animals exhibited slow and
steady increase in blood glucose levels, especially after
60 days (P < 0.0001; Fig. 2a), and exhibited significant
hyperglycemia after 180 days (P < 0.0001; Fig. 2a,
Additional file 1: Figure S7C, and Additional file 4: Table
S10). However, no change was observed in the circulat-
ing level of AChE activity (P < 0.9999; Fig. 2b, Additional
file 1: Figure S7D, and Additional file 4: Table S11).
MCP-fed animals also showed impaired glucose toler-
ance compared to untreated controls (P < 0.0001; Fig. 2c,
Additional file 1: Figure S7E, and Additional file 4: Table
S12). The experiments were repeated thrice/twice and
no significant variation between the batches was noticed
(Additional file 4: Table S10–S12). We observed similar
levels of fasting insulin between the two groups of ani-
mals (P < 0.50; Additional file 1: Figure S7F).
Fig. 2 Chronic intake of OP-induces hyperglycemia and glucose intolerance leading to oxidative stress a Periodical fasting blood glucose of
animals drinking pure water or MCP mixed water (n = 09). b Periodical plasma AChE level of animals drinking pure water or MCP mixed water
(n = 10). c Oral glucose tolerance test (OGTT) of animals drinking pure water or MCP mixed water after 180 days (n = 09). d Serum lipid peroxidation
level of animals after 180 days drinking pure water or MCP mixed water (n = 09). Horizontal lines or symbols represent mean; error bars represent s.e.m;
****P < 0.0001, **P < 0.01, P < 0.05. Unpaired two-sided student-t test. Experiments were repeated twice/thrice
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Hyperglycemia induces oxidative stress and previous
studies reported the association between OP exposure
and oxidative stress [8, 10, 27]. We noticed a significant
elevation in lipid peroxidation (P < 0.002; Fig. 2d) and
protein carbonylation (P < 0.02; Additional file 1: Figure
S8A) in the serum of MCP-fed animals. A significant in-
crease of lipid peroxidation in the liver (P < 0.003) and
kidneys (P < 0.04; Additional file 1: Figure S8B) and in-
creased protein carbonylation in liver of MCP-fed ani-
mals were observed (P < 0.02; Additional file 1: Figure
S8C). In addition, increased total antioxidant activity
was detected in the serum (P < 0.05; Additional file 1:
Figure S3D) of MCP-fed animals. Increased levels of
hepatic damage markers (LDH (P < 0.03), AST (P <
0.05), and ALT (P < 0.04)) in serum (Additional file 1:
Figure S8E) suggests free radicals mediated tissue dam-
age. Histopathology of the liver showed signs of hepatic
periportal inflammation and fibrosis (Additional file 1:
Figure S8F). Collectively, these results indicate that
chronic OP exposure induces glucose intolerance lead-
ing to oxidative stress and hepatic damage.
OP-induced glucose intolerance mediated by gut
microbiome
AChE inhibition is the prime mode of action of OP [7]
but in our study both humans and mice exposed to
chronic OPs developed hyperglycemia but no changes in
the level of plasma AChE activity is observed. OPs are
biodegradable by the microbes [16] and xenobiotics were
also reported to alter the gut microbiome and influence
the physiology and pathology of mammals [22, 23].
Hence, in the present study we analyzed the influence of
gut microbiome in OP-induced glucose dyshomeostasis.
Fecal transplantation was executed in randomly selected
animals for seven days using the fecal samples collected
from control and MCP-fed animals (Additional file 1:
Figure S9A). The animals were maintained in similar en-
vironments but in different chambers to avoid cross-
contamination. The recipients of fecal microbiota from
MCP-fed animals exhibited significant glucose intoler-
ance on comparison to recipients of control microbiota
(P < 0.05; Fig. 3a and Additional file 1: Figure S9B). The
experiments were repeated twice and no significant vari-
ation between the batches were noticed (Additional file 4:
Table S13).
To further check whether this induction of glucose in-
tolerance is specific to MCP or common to all OP, feces
from randomly selected mice were cultured anaerobic-
ally in the presence of MCP, CHL, MAL, or M.PAR and
subsequently mice were fed with these cultures
(Additional file 1: Figure S10A). This culture transplant-
ation resulted in the replication of glucose intolerance
condition (Fig. 3b). Except MAL (P < 0.60), all other pes-
ticides MCP (P < 0.01), CHL (P < 0.0001), and M.PAR (P
< 0.0003) caused significant glucose intolerance (Fig. 3b,
Additional file 1: Figure S10B, and Additional file 4:
Table S14), which is in concordance with the human
data. Together, these results indicate that gut micro-
biome plays an inevitable role in the induction of glu-
cose intolerance by OP and it seems to be a uniform
mechanism among most of the OP.
OP exposure induces OP-metabolizing machinery of gut
microbiota
Antibiotics are known to shape the physiology and gene
expression of the active human gut microbiome [22]. In
order to understand the functional effects of OP on gut
microbiome, we studied metatranscriptomics of bacterial
RNA from the caecum of control and MCP-fed animals.
Total RNA was isolated from caecum along with its con-
tent and the eukaryotic RNAs and bacterial ribosomal
RNAs (rRNAs) were selectively removed and bacterial
messenger RNA (mRNA) was enriched. RNA sequen-
cing (RNA-seq) was performed yielding millions of reads
which were annotated to the mice genome, human
microbiome database (2012), and all other RNA libraries
(Additional file 4: Table S15). To obtain a high-level view
Fig. 3 OP-induced glucose intolerance is mediated by gut microbiome
a OGTT of animals following transplant of microbiota for seven days
from pure water or MCP mixed water drinking mice (n = 08). b OGTT of
animals following seven days of transplantation of fecal cultures grown
in presence of OP (n = 06). Horizontal lines or symbols represent mean;
error bars represent s.e.m; ****P < 0.0001, **P < 0.01, P < 0.05. Unpaired
two-sided student-t test (a) or two-way ANOVA with Bonferroni
correction (b). Experiments were repeated twice
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of the transcriptional response of OPs, the number of
normalized counts assigned to each KEGG metabolic
pathway were tallied. OP treatment resulted in increased
expression of xenobiotic biodegradation and metabolism
KEGG category. As previously reported in the case of
antibiotic treatment [22], the expression of modules
linked to genetic information processing, particularly
translation, was increased while the transcription mod-
ule was relatively decreased (Fig. 4a and Additional file
4: Table S16). Analysis of KEGG module and pathway
abundance with HUMAnN and LEfSe confirmed and ex-
tended these trends: OPs induced the expression of
modules for xenobiotic metabolism, glucose metabolism,
phosphate transport, vitamin biosynthesis, nucleotide
metabolism, and translation. Further on analysis with
the metacyc enzyme database from the human micro-
biome consortium, we found a significantly increased ex-
pression of enzymes linked to OP degradation (Fig. 4b).
These enzymes include esterases (P < 0.0005), hydrolases
(P < 0.02), and lipases (P < 0.05) (Fig. 4b), which were
characterized as potential OP degraders [16].
RNA-seq analysis indicated the upregulation of OP de-
grading bacterial enzymes during chronic exposure
(Fig. 4b). To study its effect on glucose intolerance, the
animals were fed with whole fecal cultures or phosphate
buffered saline (PBS) suspended microbial cells or
Fig. 4 Chronic OP exposure activates the gut microbiome xenobiotic metabolism genes. a Percentage of normalized counts assigned to each
KEGG category module. b Expression profile of OP degrading genes expressed as reads per kilomillion counts (RPKM) (n = 3). c OGTT of animals
fed with fecal culture/suspended cells/supernatant grown in the presence or absence of MCP (n = 10). d Fecal esterase activity of the animals fed
with fecal culture/suspended cells/supernatant grown in the presence or absence of MCP (n = 6). Horizontal lines, bars, or symbols represent
mean; error bars represent s.e.m; ***P < 0.001, *P < 0.05. Unpaired two-sided student-t test (b, d) or two-way ANOVA with Bonferroni correction (c).
Experiments were repeated twice
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culture supernatant grown in presence and absence of
MCP. Glucose intolerance was induced in animals re-
ceiving MCP culture (P < 0.03) and MCP supernatant (P
< 0.04; Fig. 4c and Additional file 1: Figure S10C). In
contrast, glucose intolerance was not induced in animals
receiving MCP-suspended cells (Fig. 4c, Additional file
1: Figure S10C, and Additional file 4: Table S17). We
also observed increased fecal esterase activity in the ani-
mals exhibiting impaired glucose tolerance phenotype
(Fig. 4d, Additional file 1: Figure S10D, and Additional
file 4: Tables S18 and S19). In sum, RNA-seq analysis
and subsequent studies indicate that OP chronic expos-
ure induces the expression of OP degradation machinery
of the gut microbiome that appears to be the key mech-
anism behind impaired glucose tolerance.
Acetic acid produced by microbial degradation of OP
induces gluconeogenesis
To understand the effect of the microbial degradation of
OP on host metabolism, we executed whole metabolite
profiling of caecum tissue from control and MCP-fed
animals. The expression of metabolites was expressed as
peak area normalized to total ion chromatogram
(Additional file 4: Table S20). Subsequently, the biologic-
ally meaningful pathways, which were significantly
enriched in quantitative metabolomics data, were identi-
fied by quantitative metabolite set enrichment analysis
(MSEA) by MetaboAnalyst [28] (Additional file 1: Figure
S11 and Additional file 4: Table S21). Among the top
enriched pathways, gluconeogenesis (GNG) showed a
significantly higher fold change (P = 0.0208; Fig. 5a),
which is associated with glucose intolerance. The ex-
pression profile of key metabolites associated with GNG
showed increased expression, (Fig. 5b, Additional file 1:
Figure S12, and Additional file 4: Table S20) suggesting
the induction of GNG. In particular, a significantly ele-
vated level of glucose (P < 0.002; Fig. 5b) suggested the
enhancement of endogenous glucose production. In the
present study, glucose-6 phosphate (P < 0.02; Fig. 5b)
and citric acid (P < 0.04; Fig. 5b), which are crucial check
points in the inter-regulation of glycolysis and GNG
showed significantly elevation.
To confirm the induction of GNG, glucose-6 phos-
phatase (G6Pase) activity (a major regulatory enzyme in
gluconeogenesis [29]) was assayed in the intestine and
liver of the animals fed with control or MCP whole cul-
ture, suspended cells, and culture supernatant. Signifi-
cantly higher intestinal G6Pase activity was observed in
animals treated with MCP whole culture (P < 0.008) and
MCP supernatant (P < 0.0001; Fig. 5c and Additional file
4: Table S22). Concurrently, significant GNG was also
induced in the liver, which was evidenced by increased
G6Pase activity in animals treated with MCP whole cul-
ture (P < 0.001) and in MCP-supernatant treated animals
(P < 0.007; Fig. 5d and Additional file 4: Table S23). Ex-
pression of hepatic G6Pase is known to be involved in
glycogenolysis, which is also associated with acute OP
exposure [8] and glucose intolerance. Similar levels of
liver glycogen were observed in all groups indicating that
glycogenolysis was not induced by OP in our experiment
(P < 0.08; Additional file 1: Figure S5E and Additional
file 4: Table S24).
Short chain fatty acids (SCFA) especially acetic acid
was produced during bacterial degradation of MCP [16].
Hence, we examined the level of fecal acetate in the ani-
mals fed with MCP or control whole culture, suspended
cells, and supernatant. The feces from animals exhibiting
impaired glucose tolerance showed significantly higher
level of fecal acetate content (Fig. 5e). Similarly, the ani-
mals fed with cultures incubated in presence of other
OPs also showed increased fecal acetate content
(Additional file 1: Figure S10F). Thus, fecal acetate levels
directly correlate with impaired glucose tolerance condi-
tion. This was highlighted by the increased G6Pase ac-
tivity in liver (Fig. 5d).
To confirm whether the acetic acid produced by OP
degradation is the key factor behind OP-induced gluco-
neogenesis, we treated the animals with sodium acetate
(NaAc) orally or by rectal infusion (RI) (Additional file
1: Figure S13A) and examined for glucose intolerance.
NaAc treatment replicated the impaired glucose toler-
ance phenotype induced by OPs (Fig. 5f and Additional
file 4: Table S25). Though glucose intolerance was ob-
served in oral treatment (P < 0.05), RI induced relatively
significant glucose intolerance (P < 0.01; Fig. 5f and
S12B). We noticed significant intestinal G6Pase activity
in animals rectally infused with NaAc (P < 0.0001; Fig. 5
g), but not in the animals orally treated with NaAc (P <
0.07; Additional file 4: Table S26). In contrast, significant
hepatic G6Pase activity was observed in both groups of
animals treated with NaAc orally (P < 0.008) or by RI (P
< 0.001; Fig. 5 g and Additional file 4: Table S27). Excep-
tionally, increased glycogen content was observed in ani-
mals rectally infused with NaAc (P < 0.05; Additional file
1: Figure S13D and Additional file 4: Table S28). Collect-
ively, these results indicate that acetic acid was produced
by the gut microbial degradation of OP and thereby glu-
coneogenesis was induced in intestine and liver.
Fecal acetate and esterase activity correlates with OP
residues and human diabetic status
To examine the prevalence of a similar phenomenon of
gut microbiota-dependent OP-induced hyperglycemia in
humans, we collected fecal samples from control (n =
60) and diabetic people (n = 60) in the same population
that studied for OP residues (Additional file 2: Table S8).
Pregnant women and those having stomach/bowel-re-
lated disorders were excluded from the study. Among
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the non-diabetics, people with obesity, hypertension,
hypocholesterolemia or any other self-reported disorder,
and those on any kind of regular medications were ex-
cluded from the study and thereby only control people
were included.
We applied esterase assay to study the OP degrading
potential of fecal microbiota from diabetic and control
individuals. No significant association between fecal es-
terase activity and diabetic status (Rank sum P < 0.40;
Fig. 6a) was observed. However, positive correlation was
obtained between OP residues and fecal esterase activity
(PCC = 0.32, P > 0.01) (Additional file 2: Table S9). On
regression analysis, we observed a linear trend in the in-
crease in fecal esterase activity for every unit increase of
total OP in plasma of diabetic individuals (β = 6.4 × 10−4,
P > 0.01) (Fig. 6b). Subsequently, we checked for the
fecal acetate level by gas chromatography and found a
significantly higher acetate level among the diabetic
people (Rank sum P > 0.03; Fig. 6c and Additional file 1:
Figure S14). As observed for esterase activity, significant
correlation and linear trend were observed between total
OP and acetate level in the diabetic people (PCC = 0.35,
P > 0.01; β = 0.09, P > 0.01) (Fig. 6d). In the case of MAL,
a significant positive correlation (PCC = 0.18, P > 0.05)
was obtained for esterase activity but no correlation was
found for acetate (PCC = 0.03, P = 0.06) (Additional file
2: Table S9). On interquartile analysis, the people in the
highest quartile are largely distributed among the
Fig. 5 Gut microbial degradation of OP-induces gluconeogenesis. a Top five metabolic pathways represented by quantitative MSEA. The P values
of Q-statistics are mentioned at the end of bars. b Expression of metabolites associated with gluconeogenesis expressed as normalized peak area (n =
3). c Intestinal and (d) Hepatic glucose-6 phosphatase activity of animals fed with fecal whole culture or suspended cells or culture supernatant grown
in the presence or absence of MCP (n = 06). e Fecal acetate level of the animals fed with fecal whole culture or suspended cells or culture supernatant
grown in the presence or absence of MCP (n = 03). f OGTT of animals treated with sodium acetate (NaAc) orally and by rectal infusion (RI) (n = 08). g
Intestinal and hepatic glucose-6 phosphatase activity of NaAc treated animals (n = 08). Bars, horizontal lines, or symbols represent mean; error bars repre-
sent s.e.m; ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05 Two-way ANOVA with Bonferroni correction (f) or one-way ANOVA with Tukey post-hoc
analysis (g) or unpaired two-sided Student’s t-test (b–e). Experiments were repeated twice
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diabetic population (Additional file 1: Figure S14). Over-
all, these results suggest the prevalence of a similar
phenomenon of diabetic conditions mediated by micro-
bial degradation of OPs in humans.
Discussion
In the last few decades, the epidemic of diabetes intensi-
fied concurrently with increased consumption of syn-
thetic chemicals including OPs [30]. We detected a
probable link between direct exposure to OPs and self-
reported diabetic status in a rural population (Fig. 1a).
Previous reports also showcased OPs with increased
odds of diabetes in a dose-dependent manner [12, 14].
As periodical health camps are conducted by our Uni-
versity and Government in the study villages, most of
them are aware of their diabetic status. In concurrence
with previous reports [14, 15], we noticed that diabetes
was highly prevalent among the rural people directly ex-
posed to OPs (Fig. 1a and Additional file 1: Figure S1B),
who are majorly agricultural workers involving huge
physical work. A prevalence of nearly 50% of non-
genetic diabetics in both groups suggests that genetic
risk may not be the causative factor for increased preva-
lence of diabetes among the directly OP exposed group
(Additional file 1: Figure S1C).
To further validate the self-reported diabetes and OP
exposure, blood samples were collected. Though 10% of
self-reported diabetic people had normal glucose levels,
they were classed as diabetic since they were taking
hypoglycemic medication (Additional file 2: Table S4).
On validation of self-reported diabetes, we found 19% of
self-reported non-diabetics were newly diagnosed as dia-
betic (Additional file 2: Table S4), which adds to the bur-
den of diabetic prevalence in this community. The major
mode of action of OP is inhibition of AChE but we
found no significant changes in plasma AChE activity
with either OP exposure or HbA1c. The people with ele-
vated AChE levels were evenly distributed between the
diabetic and non-diabetic individuals and no correlation
was found with plasma OP residues (Fig. 1b, Additional
file 1: Figure S2A, and Additional file 2: Table S4). Any
changes in AChE activity, neuronal markers, or preva-
lence of neuronal diseases were not described in the
previous epidemiological studies which report the asso-
ciation between OP exposure and diabetic incidence
[12–15]. The OP residues detected in the people not dir-
ectly exposed (Fig. 1c–e, Additional file 2: Table S4) in-
dicates the draining of the OPs from farm to the public
via air, water, and eatables. Though people are majorly
exposed to OPs via food, the OPs in the small intestine
Fig. 6 Plasma OP residues correlate with fecal esterase activity and fecal acetate. Fecal samples were collected from control (n = 60) and diabetic
(n = 60) humans. a Fecal esterase activity of non-diabetic vs. diabetic individuals. b Regression plot of plasma total OPs vs. fecal esterase activity.
c Fecal acetate level of non-diabetic vs. diabetic. d Regression plot of plasma total OPs vs. fecal acetate content. Horizontal lines represent mean;
error bars represent s.e.m; *P < 0.05 Rank sum, Mann–Whitney U Test (a, c). The hollow circle represents individual values and straight line repre-
sents the trend line. PCC Pearson correlation coefficient, β regression coefficient. *P < 0.05; **P < 0.01
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enter the blood stream and re-enter the large intestine
through bile excretion. The linear trend between OP res-
idues and HbA1c shows the direct or indirect role of
OPs in the diabetic epidemic in the past few centuries.
Except MAL, all the other OPs showed a significant cor-
relation and regression with HbA1c values. MAL was
categorized under WHO Class III (slightly hazardous)
while the rest of them are under Classes I, IIa, and IIb
(extremely, highly, and moderately hazardous, respect-
ively) (Additional file 2: Table S1).
To check the diabetogenic nature of OPs, animals
treated with 10× TMDI dose of OPs for a chronic time
period resulted in significant glucose intolerance (Fig. 2a
and c) and oxidative stress (Fig. 2d and Additional file 1:
Figure S8) leading to hepatic damage (Additional file 1:
Figures S7F and S8E) with no change in AChE activity
(Fig. 2b). TMDI calculation does not include the vegeta-
bles with no MRL value, drinking water, air, soft drinks,
snacks, and other consumables. Hence, we provided the
animals with 10× TMDI dose, which is 47.2 times
(Additional file 1: Figure S7A) higher than the accept-
able daily intake (FAO/WHO, 1996). In the absence of
AChE inhibition during chronic exposure, the mechan-
ism of OP-induced glucose dyshomeostasis is not clearly
defined [8, 9].
The biodegradable nature of OPs made them an ac-
ceptable alternative to persistent organochlorines [3].
Recent studies showcased the role of gut microbiome
in the action of drugs and other chemicals [31]. Fecal
transplantation from MCP-fed animals induced glucose
intolerance (Fig. 3a and Additional file 1: Figure S8B)
and this phenotype was reproduced in animals fed with
fecal cultures grown in the presence of other OPs ex-
cept MAL (Fig. 3b and Additional file 1: Figure S9B).
This is in concordance with previous reports that MAL
induces a gradual increase in blood glucose followed by
decrease in blood glucose that can even reach
hypoglycemia [32]. Chronic OP exposure activates the
expression of OP metabolizing genes of the gut micro-
biome (Fig. 2b) and subsequent OP degradation pro-
duces acetic acid. These OP degrading enzymes are
well characterized enzymes and employed as potential
players in OP remediation projects [16]. Though the
fecal cultures grown in the presence of OPs and their
supernatants could induce glucose intolerance, the mi-
crobial cell suspension was not able to induce the same
(Fig. 4c). A similar trend was observed in esterase activ-
ity (Fig. 4d) and this indicates that byproducts of OP
degradation are able to induce glucose intolerance but
the modified microbiome with degrading potential
lacks this property. Though the microbes in cellular
suspension have OP metabolizing potential, they do not
have the substrate OPs to produce acetate and hence
glucose intolerance was not induced. While in the case
of whole culture and supernatant, the by-products of
OP metabolization, including acetate, were present,
which acts as a substrate for gluconeogenesis and
thereby glucose intolerance was induced.
Metabolomic analysis clearly showcased the induction
of GNG (Fig. 5a and b). Intestinal GNG was shown to
induce benefits in glucose control since it initiates a
neutrally mediated suppression of hepatic glucose pro-
duction [33]. However, when hepatic GNG is strongly al-
tered, e.g. when bile salts are released in the portal
blood, hepatic GNG dominates the regulatory action of
intestinal GNG [34]. Hence, due to the maximal activa-
tion of hepatic GNG, the protective effect of intestinal
GNG is not predominant in the effects of OP. Though
the liver is the primary site of GNG, this pathway is also
induced in the intestine and kidneys during specific con-
ditions. Intestinal GNG is a central signal in glucose and
energy homeostasis [33]. We observed no significant
change in the expression levels of glucogenic amino
acids, which indicates GNG is not induced by a sub-
strate effect putatively initiated by these amino acids as
substrates (Additional file 1: Figure S8). Glycogenolysis
is another potential pathway by which glucose is pro-
duced from liver glycogen using GPase. OPs such as
MPAR, MAL, and acephate were reported to induce gly-
cogenolysis and decrease liver glycogen content in ani-
mal experiments at acute and subchronic exposure [8].
However, in our study no significant change in liver
glycogen level was observed. This indicates that the
mechanism behind OP-induced glucose dyshomeostasis
may vary between acute and chronic toxicity. A pentose
phosphate pathway is yet another metabolic network
that regulates glucose homeostasis but no significant
changes were observed in the level of metabolites linked
to this pathway in our analysis (Additional file 2: Table
S16) and this is inconsistent with the previous reports.
SCFA are produced during microbial degradation of OPs
[16]. Among the SCFA, only butyrate rather than other
SCFAs is completely utilized in the intestine [35], which
is not produced by the degradation of any OPs [16].
Microbiota are proven to regulate intestinal absorption
and metabolism of fatty acids. While regarding other
SCFAs, especially acetate, only a small fraction is utilized
in the intestine and the remaining reaches the liver via
the periportal vein [36] and hepatic GNG is activated. A
linear regression between OP residues and fecal esterase
activity indicates the induction of the expression of OP
degrading genes in OP environment and this is evi-
denced by the increased fecal acetate observed in the
diabetic samples. Thus, the association between human
diabetes and fecal esterase activity and fecal acetate with
plasma OP residues signs the probable prevalence of
gut-microbiota mediated OP-induced hyperglycemia in
humans (Fig. 6).
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Conclusion
In summary, our study showcased a probable association
between plasma OP residues and diabetes with no sig-
nificant changes in plasma AChE. OPs are metabolized
by the gut microbiome to acetic acid, which is utilized as
the substrate for GNG and accounts for glucose intoler-
ance (Fig. 7). Today the words of Carson [2], “As the
tide of chemicals born of the industrial age arisen to en-
gulf our environment, a drastic change has come about
in the nature of the most serious health problem,” be-
came invincible truth. Our study revealed that gut
microbiome-mediated metabolism of OPs could be a key
risk factor for diabetes and thereby calls for the recon-
sideration of OP usage all over the world. The obser-
vance of correlation of OP residues with HbA1c and
fecal parameters suggests the establishment of environ-
mental chemicals and gut microbiota as diagnostic
markers and therapeutic targets for metabolic diseases.
In fact, OPs were once considered as a better alternative
to the persistent organochlorines but today it appears
that detailed experiments on the toxicity of these non-
persistent pesticides is needed. Hence, rather than
searching for other chemical alternatives, promotion and
development of traditional self-sustainable, nature-based




A survey was conducted among the pesticide shop
workers, pesticide applicators, and land owners in Vada-
palanji Panchayat Union, Madurai district, Tamil Nadu,
India (latitude 9.9272, longitude 78.0092; Additional file
1: Figure S1). Details on name, frequency, and volume of
insecticides commonly being used were collected. The
fungicides, herbicides, bactericides, and mineral supple-
ments were not taken into consideration. In a subse-
quent study, the people (n = 3080) from villages in
Vadapalanji Panchayat Union that incorporates Vadapa-
lanji, Manapatti, Thenpalanji, Sundarajapuram, Nagama-
lai puthur and Palkalainagar, Vellaparaipatti, and
Meenatchipatti villages of Madurai district, Tamil Nadu,
India were surveyed for their diabetic status and expos-
ure history to OPs using a questionnaire (Additional file
3). Participants under the age of 35 years and pregnant
women were excluded from the study. In addition, sex,
age, and familial diabetic history were also collected.
The diabetic status of the participants was self-reported
by answering “Yes” or “No.” Participants involved in OP
spraying, mixing, and field workers in OP-based agricul-
ture were defined as having direct exposure to OPs and
those who were not associated with OP-based agricul-
tural works were defined as having indirect exposure to
OPs.
Human blood collection
Blood samples of 5 mL were collected in EDTA-coated
tubes from a random subset of the population (n = 802)
involved in an earlier survey. The details of age, sex,
height, weight, occupation, dietary habits, smoking, alco-
hol and tobacco consumption, exposure history to pesti-
cides, prevalence of diabetes or any other diseases, and
familial diabetic history were collected using a standard
questionnaire (Additional file 5). Obesity was defined as
Fig. 7 Schematic summary of the molecular mechanism behind gut microbiome mediated OP-induced glucose intolerance. OPs (star) enter the
human digestive system via food and are metabolized into acetic acid (trapezoid) by the gut microbiota (oval). Subsequently, acetic acid was
absorbed by the intestinal cells and the majority of them were transported to the liver through the periportal vein. Eventually, acetic acid was
converted into glucose (hexagon) by gluconeogenesis in the intestine and liver and thus accounts for glucose intolerance
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body mass index (BMI) > 30 kg/m2. The collection proto-
col was approved by the internal research and review
board, ethical clearance, biosafety, and animal welfare
committee of Madurai Kamaraj University. Laboratory
personnel performing analyses of blood parameters were
all blinded and provided with only the sample ID and no
participant details.
HbA1c analysis
Diabetic status was confirmed by HbA1c analysis in whole
blood by HPLC (D10, Biorad Inc., USA). Diabetes was de-
fined as either having a history of diabetes on medications
or glycated hemoglobin (HbA1c) of ≥ 6.5% based on Inter-
national Expert Committee (IEC) recommendations.
Acetylcholine esterase assay
AChE assay was performed in blood plasma/serum using
the Amplex Red acetylcholinesterase kit (Invitrogen Inc.,
USA; A12217) as per the manufacturer’s instructions. In
this assay, AChE activity is monitored indirectly using
10-acetyl-3,7-dihydroxyphenoxazine (Amplex Red), a
sensitive fluorogenic probe for hydrogen peroxide. First,
AChE converts the acetylcholine substrate to choline,
which is oxidized by choline oxidase to betaine and
H2O2. The latter, in the presence of horseradish peroxid-
ase, reacts with Amplex Red in a 1:1 stoichiometry and
generates a highly fluorescent product, resorufin [37].
The fluorescence was measured using excitation in the
range of 545 nm and emission at 590 nm. The reactions
were performed with technical triplicates. The reference
values are 3334–7031 mU/L for males and 2504–
6297 mU/L for females.
OP residues analysis by GC/MS
Blood plasma samples were extracted by a dispersive li-
quid–liquid microextraction technique [38] by a modi-
fied method. Briefly, 200 μL of plasma sample was
spiked with 1 mg/mL of azobenzene as internal standard
followed by the addition of 20 μL of 5 N HCl and made
up to 1 mL with deionized water. Subsequently, the sam-
ple is incubated at 70 °C for 30 min to avoid the inter-
action of OPs with proteins. After cooling down to room
temperature, 150 μL of acetonitrile (dispersive solvent)
and 50 μL of chloroform (extraction solvent) mixture
was forcibly added to the sample using syringe and soni-
cated for 3 min followed by centrifugation at 10,000 rpm
for 5 min. The organic phase at the bottom of the tube
is carefully collected and dried under a gentle stream of
nitrogen gas and dissolved in 20 μL of hexane. Sample
preparation and analysis were done in a blinded fashion.
Primary stock solutions of each insecticide (1 mg/mL)
were prepared in methanol. Working standard solutions
of the compounds were prepared by combining the ali-
quots of each primary solution and diluting with hexane.
The stock solutions were stored at −20 °C in the dark
when not in use. The standards were run at different
concentrations and peak area was observed and subse-
quently linearity was established. Limit of detection
(LOD) and limit of quantification (LOQ) were deter-
mined by standard methods. The recovery efficiencies
for each individual insecticide was determined by spiking
known concentrations of insecticide and measurement
by GC/MS (Clarus 680/ 600C; Perkin Elmer Inc., USA).
The GC injector temperature was set at 200 °C. The
oven temperature program was optimized to hold at 120 °
C for 1 min and then to increase by 10 °C min−1 up to
220 °C [39]. Helium gas was used as carrier gas. The
transfer line temperature was adjusted to 280 °C. Mass
spectrometry conditions were as follows: electron
ionization source set to 70 eV, emission current 500 lA,
MS Quad 150 C, MS Source 200 °C. The mass spectrom-
eter was run in full-scan mode and in single ion monitor-
ing mode. The m/z fragments monitored for each
insecticide is provided in Additional file 1: Figure S2C.
Maintenance and breeding of animals
Mice of BALB/c strain (RRID:IMSR_HAR:1255) were
obtained from Madras University, Chennai and main-
tained and bred in an animal house at 25–28 °C with
12 h day/night cycles. The animals were fed with deion-
ized water and standard rat chow (Hindustan Lever
Limited, India) ab libitum. All the experiments in this
study were performed with female mice aged eight
weeks weighing 20–28 g and maintained in a constant
environment at 25–28 °C with 45–60% humidity. The
health status of the mice was confirmed by continuously
monitoring their activities, behavior, body weight, and
feces. The animal protocols used in this study were ap-
proved by the internal research and review board, ethical
clearance, biosafety, and animal welfare committee of
Madurai Kamaraj University.
Administration of monocrotophos to animals
The mice were provided MCP (Sigma-Aldrich Inc., USA;
361173) at 10× TMDI dose [6] (28 μg/kg bodyweight/
day) directly in drinking water for 180 days. The food
and liquid intake and animal activity were monitored
daily. The body weight of the animals was documented
every 30 days.
Measurement of fasting blood glucose
The animals were allowed for overnight fasting prior to
blood glucose measurement. The fasting glucose was
measured using a biosensor based glucometer [40]
(Johnson & Johnson Inc., USA; OneTouch) with a drop
of blood from the tail vein and expressed as mg/dL.
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Oral glucose tolerance test
OGTT was performed to analyze how quickly the glu-
cose is cleared from the blood [41]. The animals were
fasted overnight prior to execution of OGTT, blood was
sampled by the tail vein, and glucose was measured
using the glucometer (0 min). Subsequently, the animals
were gavaged with glucose solution (1.5 g/kg body
weight) and blood glucose was monitored at 15, 30, 60,
90, and 120 min. The data were plotted in blood glucose
versus time curve and glycemic response was expressed
as area under the curve (AUC, × 103).
Harvest of organs
The animals were anesthetized by subcutaneous injec-
tion of ketamine (100 mg/kg body weight). The blood
was collected by cardiac puncture and the organs includ-
ing the brain, heart, liver, kidneys, and large intestine
were harvested and perfused in sterile PBS (10× g/ l:
25.6 Na2HPO4, 80 NaCl, 2.0 KCl, 2.0 KH2PO4. pH 7.2)
and stored at −80 °C.
Serum insulin
Insulin level in the serum was determined by immu-
noenzymometric assay based kit (Monobind Inc., USA;
5825–300) as per the manufacturer’s instructions.
Preparation of tissue homogenate
A total of 100 mg of the tissue was homogenized in
1 mL RIPA buffer (Sigma-Aldrich Inc., USA; R0278),
supplemented with 100 μL of cocktail protease inhibitors
(Sigma-Aldrich Inc., USA; P8340), and incubated in ice
for 20 min. The homogenate was centrifuged at
12,000 rpm for 20 min at 4 °C and the supernatant was
collected, aliquoted, and stored at −80 °C.
Protein estimation
The amount of protein in serum/tissue homogenate was
estimated by Bradford assay [42] (Sigma-Aldrich Inc.,
USA; B6926) as per the manufacturer’s instructions. Bo-
vine serum albumin was used as a standard and the re-
actions were performed with technical triplicates.
Protein carbonylation assay
The carbonyls produced by oxidation of protein mea-
sured spectrophotometrically by the dinitrophenyl hy-
drazine (DNPH) method [43]. Briefly, 100 μL of the
serum/tissue homogenate were mixed with 400 μL of
10 mM DNPH dissolved in 2.5 M HCl and incubated for
60 min and the protein was precipitated with an equal
volume of trichloroacetic acid (TCA) (10%). The result-
ant pellet was washed with 1:1 ethanol:ethyl acetate mix-
ture and resuspended in 250 μL of 6 M guanidine HCl.
The protein hydrozones were measured spectrophoto-
metrically at 370 nm. The corrected absorbance (CA)
for each sample was calculated by the difference between
corresponding control. The concentration of protein car-
bonyls (nM) was determined as follows: ((CA)/0.011)
(250/100)). The reactions were performed with technical
triplicates.
Lipid peroxidation assay
The lipid peroxidation was determined by estimating
malondialdehyde (MDA) [44] with minor modifications.
Briefly, 100 μL of tissue homogenate was added with
200 μL of ice cold 10% TCA to precipitate the protein
and kept in ice for 15 min. After incubation, the samples
were centrifuged at 2200 rpm for 15 min at 4 °C. A total
of 200 μL of supernatant was added with equal volume
of 0.67% thiobarbituric acid (TBA) and then incubated
in a boiling water bath for 10 min. 1,1,3,3’-tetramethoxy-
propane was used as the standard. The color developed
was read at 532 nm and the amount of MDA was
expressed as nM/mg protein. The reactions were per-
formed with technical triplicates.
Total antioxidant assay
The total antioxidant assay in the serum was executed
using the total antioxidant kit (Sigma-Aldrich Inc., USA;
CS0790) as per the manufacturer’s instructions. The
principle of this assay is the formation of a ferryl
myogloblin radical from metmyoglobin and hydrogen
peroxide, which oxidizes the ABTS (2,2’-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) to produce a radical
cation, ABTS•+, a soluble green chromogen that can be
determined spectrophotometrically at 405 nm [45]. Tro-
lox, a water-soluble vitamin-E analog, serves as the
standard. The reactions were performed with technical
triplicates. The antioxidant concentration was expressed
in mM relative to the concentration of the Trolox
standard.
Histopathology
The perfused hepatic tissue was fixed with 10% formal-
dehyde and paraffin embedded by standard methods.
The embedded tissues were sliced into 5-μm thin sec-
tions using rotatory microtome. The sections were
stained with hematoxylin and eosin and mounted on
slides. Finally, the tissue morphology was examined by
light microscopy, recorded, and analyzed by a qualified
clinical pathologist in blinded fashion.
Fecal transplantation
After 180 days of experiment, 200 mg of the fecal mater-
ial from animals drinking pure water or MCP mixed
water was collected and suspended in 5 mL of PBS,
mixed and incubated for 5 min at room temperature for
separation by gravity, and the upper phase was collected.
The mice were randomly selected for the study and
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allowed for 4 h fasting before fecal transplantation. Mice
were gavaged with 200 μL of suspension per day for
seven consecutive days [27]. The mice gavaged with fecal
suspension were maintained in a separate, adjacent glass
chambers to avoid cross-contamination. Similar condi-
tions of temperature, humidity, water, and feed were
maintained between the control and fecal transplanted
group. At the end of the week, an OGTT was conducted
as described above. Twenty-four hours after OGTT, the
mice were sacrificed and the intestine and liver were col-
lected for other assays.
Ex vivo culture and feeding
A total of 200 mg of fecal content from randomly se-
lected mice from different cages were collected and sus-
pended in 5 mL of sterile PBS and vortexed. The
mixture was allowed to stand at room temperature for
5 min for separation by gravity and the supernatant was
collected. One milliliter of the supernatant was inocu-
lated in 9 mL of Robertson cooked meat medium (com-
position g/L: beef heart solids 98; proteose peptone 20;
dextrose 2; sodium chloride 5. pH 7.2) supplemented
with different OPs (MCP, CHL, MAL, and M.PAR)
(Sigma-Aldrich Inc., USA; 36173, 45395, 36143, 36187)
at 0.2 mg/mL concentration and incubated at anaerobic
condition at 37 °C for nine days [22, 27]. To maintain
logarithmic growth, the culture was subcultured every
three days. After nine days of growth, part of the culture
was centrifuged at 3000 rpm for 5 min and the super-
natant was collected while the remaining pellet was dis-
solved in same volume of PBS. As mentioned above in
the fecal transplantation protocol, the mice were admin-
istered with 200 μL of whole culture/suspended cells/
supernatant continuously for seven days and finally
OGTT was performed. As described above, the mice fed
with cultures were maintained in separate, adjacent glass
chambers with the same environment of temperature,
humidity, water, and feed. Twenty-four hours after
OGTT, the mice were sacrificed and the intestine and
liver were collected for other assays.
Metagenomic RNA isolation
Total RNA was extracted from the ceacal tissue along
with its contents using TRI reagent (Sigma-Aldrich Inc.,
USA; T9424) as per the manufacturer’s instructions. The
integrity was checked in the agarose gel and quality and
quantity was determined spectrophotometrically.
Enrichment of bacterial RNA
Bacterial RNA was enriched from the total RNA by
using MICROBEnrich kit (Ambion Inc., USA; AM1901)
as per the manufacturer’s protocol. Here, hybridization
capture technology was used to remove human, mouse,
and rat RNA (both mRNA and rRNA) from complex
host-bacterial RNA populations, leaving behind enriched
microbial total RNA. In the first step of the procedure,
host-bacterial total RNA is incubated with a mixture of
capture oligonucleotides that bind the mammalian 18S
and 28S rRNAs and polyadenylated RNAs. Next, the
rRNA/oligo nucleotide hybrids and all polyadenylated
mRNAs are removed from the mixture with
oligonucleotide-derivatized magnetic beads. To ensure
complete removal of eukaryotic mRNAs, complementary
DNA was constructed with oligo-d(T) primers and poly-
merase chain reaction for the mouse GAPDH gene was
executed and checked.
Enrichment of bacterial mRNA
Bacterial mRNA was enriched in the purified RNA by
removing the 16S and 23S rRNAs using a MICROBEx-
press kit (Ambion Inc., USA; AM1905) as per the
manufacturer’s instructions. The method employs a
modification to sandwich capture hybridization proto-
cols that were developed for the capture and detection
of specific nucleic acid molecules with probes conju-
gated to magnetic beads. The bound RNA was separated
by using magnetic field and the unbound RNA was dis-
solved in RNase free water. The enrichment of bacterial
mRNAs and removal of rRNAs was confirmed by bioa-
nalyzer (Agilent Inc., USA) analysis.
RNA sequencing and analysis
RNA library was constructed using TruSeq kit (Illumina
Inc., USA) as per the manufacturer’s instructions. RNA-
seq was done at Centre for Cellular & Molecular Plat-
forms (Government of India), Bangalore with paired-end
reads in Illumina HiSeq 1000 machine. The sequencing
was performed in a blinded way. Raw data were proc-
essed using the Solexa software. Low-quality reads were
filtered according to the base quality value. The reads
were mapped with mouse genome, murine mRNAs,
transfer RNAs, and rRNAs by Bowtie 2 [46] and the an-
notated sequences were removed.
We used a reference database of human microbiome
to perform functional analysis of the RNA-seq data. This
reference included 538 draft and finished bacterial
genomes from the human microbiome consortium.
High-quality reads were mapped using Bowtie 2 to our
reference bacterial database. Subsequently, using the
KEGG database, all predicted proteins from the refer-
ence genome database were annotated with KEGG
orthologous groups (KOs). For query genes with mul-
tiple matches, the annotated reference gene with the
lowest e value was used. When multiple annotated genes
with an identical e value were encountered after a
BLAST query, we included all KOs assigned to those
genes. The number of transcripts assigned to each gene
was then tallied and normalized to RPKM. To account
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for genes that were not detected owing to limited se-
quencing depth, a pseudocount of 0.01 was added to all
samples. Genes were grouped by taxa, genomes, and KO
by calculating the cumulative RPKM for each sample.
HUMAnN [47] was used for metabolic reconstruction
from metagenomic data followed by LefSe [48] analysis
with bootstraping to identify significant biomarkers. The
reads were annotated to metacyc enzyme database from
the human microbiome consortium using BLASTN. The
number of transcripts assigned to each enzyme were
then tallied and normalized to RPKM. The enzymes of
the same class were summed and expressed as single
enzyme.
Esterase assay
A total of 200 μL of the culture was centrifuged at
12,000 × rpm for 10 min and the pellet was suspended in
200 μL of sterile PBS. Eighty microliters of suspension
were used for esterase assay with ethyl butyrate as sub-
strate as per Lisboa et al. [49]. The formation of carbox-
ylic acid due to hydrolysis of substrates mediated by
esterase causes a reduction in the pH, which changes
the color of the medium from blue to yellow. This reac-
tion can be observed or monitored spectrophotometric-
ally at 616 nm. We used ethyl butyrate (Sigma Aldrich
Inc., USA; 109959) as the substrate and bromothymol
blue (Himedia labs, India; GRM120) as the pH indictor.
Metabolomics
The tissue processing for metabolomics was carried out in
NIH Centre for Metabolomics, University of California,
USA as per standard operating procedure [50]. The ana-
lysts were blinded of the sample information. A total of
50 mg of caecum tissue cleared of fecal matter was taken
in a 25-mL polypropylene centrifuge tube and 2.5 mL of
extraction solvent (acetonitrile:isopropanol:water 3:3:2)
was added and homogenized for 45 s. In between every
homogenization, the homogenizer was cleaned with solu-
tions of methanol, acetone, water, and the extraction solv-
ent. The homogenate was centrifuged at 2500 rpm for
5 min. The supernatant was aliquoted 2 × 500 μL and one
of them stored at −20 °C for back up. The other aliquot of
500 μL was evaporated to complete dryness in a centrivap
cold trap concentrator. The dried aliquot was resuspended
in 500 μL of degassed 50% acetonitrile and centrifuged for
2 min at 14,000 rcf. The supernatant was collected in a
fresh tube and evaporated to dryness in a centrivap cold
trap concentrator and finally submitted to derivatization.
Primary metabolism by ALEX-CIS GCTOF MS
Data were acquired using the following chromatographic
parameters as described by Fiehn et al. [51]. A Rtx-5Sil
MS column (Restek Corporation) was used with helium
as a mobile phase. A total of 0.5 μL of samples were
injected at 25 splitless time into a multi-baffled glass
liner with injection temperature of 50 °C ramped to
250 °C by 12 °C s−1. Oven temperature was programmed
at 50 °C for 1 min, ramp at 20 °C per minute to 330 °C
which was held constant for 5 min. Data processing and
data reporting were done by NIH Centre for
Metabolomics.
Raw results data were normalized to reduce the impact
between-series drifts of instrument sensitivity, caused by
machine maintenance, aging, and tuning parameters.
We used a variant of vector normalization in which the
sum of all peak heights for all identified metabolites ex-
cluding the unknown for each sample was calculated
and termed as mTIC. mTIC was used to avoid the po-
tential non-biological artifacts for the biological normali-
zations, such as column bleed, plasticizers, or other
contaminants. mTIC averages were determined between
different treatment groups and following equation was
used for normalization of metabolite i of sample j:
Metaboliteij; normalized ¼ metaboliteij; raw= mTICj
 
 mTICaverage
This normalization is relative semi-quantification and
expressed as normalized peak heights.
Quantitative metabolite set enrichment analysis
MSEA is a way to identify biologically meaningful pat-
terns that are significantly enriched in quantitative meta-
bolomics data and was carried out using the tool from
MetaboAnalyst [28, 52]. Over-representation analysis
was implemented using the hypergeometric test to
evaluate whether a particular metabolite set is repre-
sented more than expected by chance within the given
compound list. One-tailed P values are provided after
adjusting for multiple testing.
Glucose-6 phosphatase assay
Fifty milligrams of liver/colon tissue were homogenized
in 500 μL of RIPA buffer with protease inhibitors and
the final homogenate was collected. Amount of inor-
ganic phosphorus (Pi) released was assayed using
Taussky-Shorr method [53]. Briefly, 150 μL of 100 mM
Tris buffer (pH: 6.5) was mixed with 100 μL of 200 mM
glucose-6 phosphate (Sigma-Aldrich Inc., USA; G7879)
and incubated at 37 °C for 5 min. Subsequently, 10 μL
of tissue homogenate was added, mixed, and incubated
again at 37 °C for 5 min. The reaction was terminated
by the addition of 90 μL of 10% TCA and incubation at
25 °C for 5 min. Finally, the mixture was centrifuged at
4000 rpm for 10 min and the supernatant was collected.
The amount of Pi released was measured by mixing the
supernatant or inorganic Pi solution (Sigma-Aldrich Inc.,
USA; P3869) with equal volume of Taussky-Shorr color
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reagent (10% ammonium molybdate prepared in 5 M
sulphuric acid 10 mL, ferrous sulfate heptahydrate 5 g in
100 mL of distilled water) and incubated at 25 °C for
6 min. Finally, the absorbance was read at 660 nm. Spe-
cific glucose-6 phosphatase (G6Pase) activity was cleared
of the contribution of non-specific phosphohydrolase ac-
tivities by subtracting the activity toward 20 mMβ-
glycerophosphate [54] (Sigma-Aldrich Inc., USA; G9422)
and finally net G6Pase activity was expressed as μg of Pi
released per mg of protein.
Glycogen assay
A total of 100 mg of liver tissue was homogenized in
500 μL of 3% TCA and the homogenate was centrifuged
at 3000 rpm for 5 min. Five volumes of cold 95% ethanol
were added to the supernatant and left overnight at
room temperature to precipitate glycogen. After a short
spin for 10 s, the ethanolic supernatant was discarded
and the pellet was dissolved in 250 μL of deionized
water. Blank and standards (0.5 mg/mL of glucose) were
prepared with same volume of deionized water. A total
of 1.25 mL of anthrone reagent (anthrone 50 mg, thio-
urea 1 g, H2SO4 72 mL in 100 mL deionized water) was
added to all tubes and incubated at boiling temperature
for 15 min. After cooling, the absorbance was measured
at 620 nm against the blank. Amount of glycogen (mg/
100 g of tissue) = DU/DS × 0.1 × volume of extract/gram
of tissue × 100 × 0.9 where DU = absorbance of samples
and DS = absorbance of glucose standard [55].
Administration of sodium acetate
The mice were fasted for 4 h prior to the experiment.
NaAc (100 mg/ kg body weight) was administered either
orally using gavage or by RI continuously for seven days.
Before RIs, the mice were handled gently and allowed to
defecate and the complete defecation was confirmed by
softly pressing at the distal end of the rectum. The mice
were handled inversely and NaAc was administered in a
maximum volume of 20 μL using 2–20 μL tips via
micropipette. Finally, OGTT was performed by standard
protocols. The animals were sacrificed a minimum of
24 h after OGTT and the organs were harvested.
Collection of human fecal samples
Fecal samples were collected from the diabetic (n = 60)
and control people (n = 60) from the population earlier
studied for HbA1c and OP analysis. People with bowel
or stomach-related issues were excluded from the study.
The control volunteers were confirmed for absence of
obesity, hypertension, dyslipidemia, or other issues. The
collection protocol was approved by the internal re-
search and review board, ethical clearance, biosafety, and
animal welfare committee of Madurai Kamaraj Univer-
sity. In addition, the project details were explained and
their details in previous questionnaire were reconfirmed
and new informed consent was obtained (Additional file
6). Subsequently, the next day early morning fecal sam-
ples were collected and stored immediately in ice. The
samples were transported to the laboratory within 1 h
and stored in −80 °C. The analysts performing the fecal
parameters were blinded and unaware of the diabetic or
OP exposure status of the samples.
Short chain fatty acid quantification in feces
A total of 100 mg of feces was weighed and suspended in
2 mL of sterile PBS and vortexed for 1 min. The mixture
was centrifuged at 3000 × g for 10 min. Five microliters of
the supernatant was diluted 1:100 with sterile PBS. Five
microliters of ethyl butyrate (Sigma-Aldrich; 109959) was
added as internal standard to a final concentration of
5 mM. Subsequently, 250 μL of concentrated HCl was
added followed by the addition of 1 mL of diethyl ether
(Merck; LiChrosolv). The mixture was vortexed for 1 min
and centrifuged at 3000 × g for 10 min. A total of 750 μL
of upper phase was collected and derivatized with 120 μL
of N-tert-Butyldimethylsilyl-N-methyltrifluoroacetamide
(MTBSTFA) containing 1% tert-butyldimethylchlorosilane
(TBDMSCI) (Sigma-Aldrich Inc., USA; 375934) by incu-
bating at 80 °C for 20 min. The mixture was incubated at
room temperature for 48 h to ensure complete derivatiza-
tion. Gas chromatography was executed as described by
Frost et al. [56] by flame ionization detector. The GC in-
jector and detector temperatures were set at 275 °C. The
oven temperature program was optimized to hold at 63 °C
for 3 min and then to increase by 10 °C min−1 up to 190 °
C. Helium gas was used as carrier gas. The transfer line
temperature was adjusted to 280 °C. External standards
for acetate were prepared at concentrations of 25, 12.5,
6.25, 1.25, and 0.625 mM and ethyl butyric acid was used
as the internal standard at a concentration of 100 mM.
Reported values were normalized according to the weight
of original sample used.
Statistics
All statistical analyses were performed using the statis-
tical softwares SPSS version 20.0 and GraphPad Prism
version 6.01. For association studies in survey, age and
sex adjusted ORs and 95% CIs were calculated. For hu-
man studies, the non-parametric Mann–Whitney U test
was employed. Pearson correlation and linear regression
were performed to demonstrate the strength of relation-
ship between two parameters. Plasma OP residues were
categorized in quartiles based on the weighted sample
distribution. For each OP, we used logistic regression to
estimate ORs and CI levels for diabetes by comparing
each quartile with the lowest quartile. We included likely
or suspected confounders in models based on previously
published data. In each analysis, we also evaluated the
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significance of the differences of the average proportion
of diabetics across the four quartiles of the model by a
generalized maximum likelihood Wald χ2 test. Our re-
gression models were fitted with appropriate degrees of
adjustment. We adjusted for age, sex, familial diabetic
history, and BMI.
The following statistical analyses were used for animal
studies: a two-way ANOVA with Bonferroni post-hoc
analysis was used to compare between groups in differ-
ent time-points and one-way ANOVA with Tukey’s post-
hoc analysis or unpaired two-sided Student t-test was
used to compare either between multiple or between
two groups, respectively. The batch difference between
replicate/triplicates were studied by a two-way ANOVA
with Bonferroni post-hoc analysis. In all relevant panels,
symbols, bars, or horizontal lines represent the mean
and error bars represent s.e.m. For mouse experiments,
cohort sizes match common practice of the described
experiments and are repeated twice or thrice. For human
experiments, sample size was chosen to validate statis-
tical analyses. No data points were excluded from ana-
lyses in mice or human studies. P < 0.05 was considered
statistically significant in all analyses. *P < 0.05, **P <
0.01, ***P < 0.001, ****P < 0.0001.
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